Blog
- All
- News
Webinar: How to analyse SARS-CoV-2 data with Shivom
The rapid emergence of COVID-19 across the world has led to massive mortality and morbidity. The genome sequencing of the coronavirus (SARS-CoV-2) can provide clues regarding how the virus has evolved and variants within the genome. In this 60 minute webinar, Shivom’s VP of Product explains the fundamentals of analysing SARS-Cov-2 data on our …
Continue reading “Webinar: How to analyse SARS-CoV-2 data with Shivom”
- All
- News
Webinar: How to analyse SARS-CoV-2 data with Shivom
The rapid emergence of COVID-19 across the world has led to massive mortality and morbidity. The genome sequencing of the coronavirus (SARS-CoV-2) can provide clues regarding how the virus has evolved and variants within the genome. In this 60 minute webinar, Shivom’s VP of Product explains the fundamentals of analysing SARS-Cov-2 data on our …
Continue reading “Webinar: How to analyse SARS-CoV-2 data with Shivom”
Shivom Launches v2.0; Delivering a Library of Multi-Omics COVID-19 Pipelines
Shivom Ventures Limited releases v2.0 which provides researchers with various new features including a library of multi-omics COVID-19 pipelines. London, United Kingdom – April 16, 2019 – Shivom, a biotechnology data discovery and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has released v2.0. Users can now …
Continue reading “Shivom Launches v2.0; Delivering a Library of Multi-Omics COVID-19 Pipelines”
Post-MVP Launch Management Changes: Henry Ines to stay on in Emeritus role; Axel Schumacher to return as CEO
Shivom Ventures Limited announced today Henry Ines will restore Axel Schumacher as Chief Executive Officer and stay on as CEO Emeritus. Additionally, Shivom has tapped Nate Raine for the Chief Operation Officer role and for Meer Ali to become the Chief Technology Officer. London, United Kingdom – 8th August – Shivom announced today that Henry …
- Item Type
- News
Webinar: How to analyse SARS-CoV-2 data with Shivom
The rapid emergence of COVID-19 across the world has led to massive mortality and morbidity. The genome sequencing of the coronavirus (SARS-CoV-2) can provide clues regarding how the virus has evolved and variants within the genome. In this 60 minute webinar, Shivom’s VP of Product explains the fundamentals of analysing SARS-Cov-2 data on our …
Continue reading “Webinar: How to analyse SARS-CoV-2 data with Shivom”
Shivom Launches v2.0; Delivering a Library of Multi-Omics COVID-19 Pipelines
Shivom Ventures Limited releases v2.0 which provides researchers with various new features including a library of multi-omics COVID-19 pipelines. London, United Kingdom – April 16, 2019 – Shivom, a biotechnology data discovery and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has released v2.0. Users can now …
Continue reading “Shivom Launches v2.0; Delivering a Library of Multi-Omics COVID-19 Pipelines”
Post-MVP Launch Management Changes: Henry Ines to stay on in Emeritus role; Axel Schumacher to return as CEO
Shivom Ventures Limited announced today Henry Ines will restore Axel Schumacher as Chief Executive Officer and stay on as CEO Emeritus. Additionally, Shivom has tapped Nate Raine for the Chief Operation Officer role and for Meer Ali to become the Chief Technology Officer. London, United Kingdom – 8th August – Shivom announced today that Henry …
Shivom Releases MVP; Offering Clinical SaaS-based Automated Data Analytics
Shivom Ventures Limited releases its MVP which provides researchers with a Clinical SaaS-based platform to search for datasets and run genomic pipelines in three clicks of the mouse. London, United Kingdom – July 29, 2019 – Shivom, a biotechnology data discovery and analysis company optimising the way DNA is shared, secured and analysed through blockchain …
Continue reading “Shivom Releases MVP; Offering Clinical SaaS-based Automated Data Analytics”
Shivom and cc-TDI to Advance Clinical Research for Hepatoblastoma & Other Rare Pediatric Diseases
Shivom Ventures Limited (“Shivom”) and Children’s Cancer Therapy Development Institute (“cc-TDI”) enter into a Memorandum of Understanding (MOU) to explore a partnership for advancing clinical research and drug discovery for rare pediatric genetic diseases. LONDON and PORTLAND – July 10, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, …